IVAN ROSAS to Lung Diseases
This is a "connection" page, showing publications IVAN ROSAS has written about Lung Diseases.
Connection Strength
1.315
-
Telomeres in lung disease. Transl Res. 2013 Dec; 162(6):343-52.
Score: 0.319
-
Lymphangioleiomyomatosis: circulating levels of FGF23 and pulmonary diffusion. J Bras Pneumol. 2023; 49(2):e20220356.
Score: 0.160
-
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity. Nat Commun. 2021 07 14; 12(1):4314.
Score: 0.141
-
Lung transplantation and systemic sclerosis. Ann Transplant. 2000; 5(3):38-43.
Score: 0.127
-
Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis. Chest. 2018 11; 154(5):1070-1082.
Score: 0.116
-
The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death. Transplantation. 2017 09; 101(9):2207-2212.
Score: 0.108
-
An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases. Ann Am Thorac Soc. 2017 Aug; 14(8):1239-1247.
Score: 0.107
-
Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction. J Heart Lung Transplant. 2018 03; 37(3):340-348.
Score: 0.105
-
Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responses. Clin Immunol. 2014 Nov; 155(1):60-70.
Score: 0.087
-
Association of Insulin Resistance With Radiographic Lung Abnormalities and Incident Lung Disease: The Framingham Offspring Study. Diabetes Care. 2025 Jan 01; 48(1):143-148.
Score: 0.045